Sarepta Therapeutics, Inc.

( )
SRPT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -0.14%345.270.0%$4303.39m
BNTXBioNTech SE 1.83%297.750.0%$826.99m
NVAXNovavax, Inc. -0.81%133.9079.4%$752.66m
AMGNAmgen, Inc. -0.26%208.141.4%$524.82m
REGNRegeneron Pharmaceuticals, Inc. 0.00%592.152.7%$478.99m
SNSSSunesis Pharmaceuticals, Inc. 0.00%6.210.7%$434.10m
GILDGilead Sciences, Inc. -0.66%67.281.0%$395.23m
CCXIChemoCentryx, Inc. -0.65%33.502.9%$383.97m
ILMNIllumina, Inc. -0.21%416.333.3%$356.45m
XLRNAcceleron Pharma, Inc. 0.00%173.785.3%$335.39m
OCGNOcugen, Inc. 5.57%9.660.0%$320.25m
VRTXVertex Pharmaceuticals, Inc. -0.15%183.801.9%$273.65m
BIIBBiogen, Inc. 0.00%271.121.8%$271.81m
XENEXenon Pharmaceuticals, Inc. 0.00%30.570.4%$164.85m
CRSPCRISPR Therapeutics AG 1.57%96.550.6%$161.56m

Company Profile

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.